株冶集團(600961.SH):資產重組事項定於12月28日上會
格隆匯12月22日丨株冶集團(600961.SH)公佈,根據中國證監會官網公佈的《併購重組委2022年第27次工作會議公吿》,中國證監會上市公司併購重組審核委員會(“併購重組委”)定於2022年12月28日上午9:00召開工作會議,審核公司發行股份及支付現金購買資產並募集配套資金暨關聯交易事項。公司已向中國證監會上市公司監管部出具了《株洲冶煉集團股份有限公司保證不影響和干擾上市公司併購重組審核委員會審核工作的承諾函》。
根據《上市公司重大資產重組管理辦法》《關於完善上市公司股票停復牌制度的指導意見》等相關規定,公司股票將在併購重組委工作會議召開當日停牌,待公司收到併購重組委審核結果後公吿並復牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.